Remegen Co Stock Performance
| REGMF Stock | USD 9.93 0.00 0.00% |
RemeGen Co holds a performance score of 8 on a scale of zero to a hundred. The company holds a Beta of 4.84, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, RemeGen Co will likely underperform. Use RemeGen Co information ratio, skewness, as well as the relationship between the Skewness and day typical price , to analyze future returns on RemeGen Co.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in RemeGen Co are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile primary indicators, RemeGen Co reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 2.8 B | |
| Total Cashflows From Investing Activities | -637.9 M |
RemeGen |
RemeGen Co Relative Risk vs. Return Landscape
If you would invest 506.00 in RemeGen Co on September 26, 2025 and sell it today you would earn a total of 487.00 from holding RemeGen Co or generate 96.25% return on investment over 90 days. RemeGen Co is currently producing 1.8392% returns and takes up 16.9108% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than RemeGen, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
RemeGen Co Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for RemeGen Co's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as RemeGen Co, and traders can use it to determine the average amount a RemeGen Co's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1088
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | REGMF | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average RemeGen Co is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of RemeGen Co by adding it to a well-diversified portfolio.
RemeGen Co Fundamentals Growth
RemeGen Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of RemeGen Co, and RemeGen Co fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on RemeGen Pink Sheet performance.
| Return On Equity | 0.0634 | |||
| Return On Asset | 0.01 | |||
| Profit Margin | 0.15 % | |||
| Operating Margin | 0.02 % | |||
| Current Valuation | 5.29 B | |||
| Shares Outstanding | 189.58 M | |||
| Price To Earning | 264.15 X | |||
| Price To Book | 14.84 X | |||
| Price To Sales | 3.65 X | |||
| Revenue | 1.42 B | |||
| EBITDA | 281.58 M | |||
| Cash And Equivalents | 3.82 B | |||
| Cash Per Share | 7.08 X | |||
| Total Debt | 46.52 M | |||
| Debt To Equity | 0.01 % | |||
| Book Value Per Share | 9.73 X | |||
| Cash Flow From Operations | 263.63 M | |||
| Earnings Per Share | 0.08 X | |||
| Total Asset | 4.16 B | |||
About RemeGen Co Performance
By analyzing RemeGen Co's fundamental ratios, stakeholders can gain valuable insights into RemeGen Co's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if RemeGen Co has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if RemeGen Co has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
RemeGen Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of biologics for the treatment of autoimmune, oncology, and ophthalmic diseases with unmet medical needs in Mainland China and the United States. The company was incorporated in 2008 and is headquartered in Yantai, the Peoples Republic of China. Remegen is traded on OTC Exchange in the United States.Things to note about RemeGen Co performance evaluation
Checking the ongoing alerts about RemeGen Co for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for RemeGen Co help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| RemeGen Co is way too risky over 90 days horizon | |
| RemeGen Co appears to be risky and price may revert if volatility continues | |
| About 34.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing RemeGen Co's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether RemeGen Co's stock is overvalued or undervalued compared to its peers.
- Examining RemeGen Co's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating RemeGen Co's management team can have a significant impact on its success or failure. Reviewing the track record and experience of RemeGen Co's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of RemeGen Co's pink sheet. These opinions can provide insight into RemeGen Co's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for RemeGen Pink Sheet analysis
When running RemeGen Co's price analysis, check to measure RemeGen Co's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RemeGen Co is operating at the current time. Most of RemeGen Co's value examination focuses on studying past and present price action to predict the probability of RemeGen Co's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RemeGen Co's price. Additionally, you may evaluate how the addition of RemeGen Co to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |